We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Chugai and Debiopharm Announce an Exclusive License Agreement for FF284

News   Jan 08, 2013

 
Chugai and Debiopharm Announce an Exclusive License Agreement for FF284
 
 
 

RELATED ARTICLES

Molecular Switch May Serve as New Target for Cancer and Diabetes Therapies

News

If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A recently discovered mechanism has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases.

READ MORE

New Method of Diagnosing Cancer with Malaria Protein

News

Researchers have discovered a method of diagnosing a broad range of cancers at their early stages by utilizing a particular malaria protein, which sticks to cancer cells in blood samples.

READ MORE

Making Malignant Brain Tumors Self-Destruct

News

Aggressive brain tumour cells taken from patients self-destructed after being exposed to a chemical in laboratory tests

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE